Back to search
FDAFDA · Food and drugs·Recall number D-1392-2020

Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12

Published July 29, 2020 · Recall initiated: June 17, 2020

Summary

FDA records drug Class III recall D-1392-2020, published July 29, 2020 and initiated June 17, 2020. Recalling firm: HF Acquisition Co. LLC; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 6122639, Exp. Date 08/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

What to do

Voluntary: Firm initiated · Letter

Get an email if FAMOTIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FAMOTIDINE
Manufacturer
HF Acquisition Co. LLC
Distributor
The vials were distributed to one consignee located in CT.
UPC
0363323739119
Lot
Lot #: 6122639, Exp. Date 08/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12 recalled?

Yes. FDA published recall D-1392-2020 on July 29, 2020. Reported hazard: TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FAMOTIDINE. UPC: 0363323739119.